How have BLAC shares performed in 2024?

Bellevue Life Sciences Acquisition's stock was trading at $10.50 at the start of the year. Since then, BLAC stock has increased by 2.2% and is now trading at $10.73. View the best growth stocks for 2024 here .

Are investors shorting Bellevue Life Sciences Acquisition?

Bellevue Life Sciences Acquisition saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 100 shares, a decline of 92.3% from the April 30th total of 1,300 shares. Based on an average daily volume of 22,600 shares, the days-to-cover ratio is currently 0.0 days. View Bellevue Life Sciences Acquisition's Short Interest .

Who are Bellevue Life Sciences Acquisition's major shareholders?

Bellevue Life Sciences Acquisition's stock is owned by a variety of institutional and retail investors. Top institutional investors include Berkley W R Corp (5.74%), Wealthspring Capital LLC (0.61%) and K2 Principal Fund L.P. (0.60%).

How do I buy shares of Bellevue Life Sciences Acquisition?

Shares of BLAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:BLAC

Bellevue Life Sciences Acquisition (BLAC) Stock Price, News & Analysis

→ Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad)

Free BLAC Stock Alerts

$10.73

0.00 (0.00%)

(As of 05/31/2024 ET)

Compare

Today's Range: $10.73
▼
$10.73
50-Day Range: $10.66
▼
$10.91
52-Week Range: $10.18
▼
$11.60

Volume: N/A
Average Volume: 6,923 shs
Market Capitalization: $60.33 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Ownership SEC Filings Short Interest Trends

Get Bellevue Life Sciences Acquisition alerts:

Ad The Freeport Society

Next President (Not Trump. Not Biden.)

Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.

Click here to see why it will be ______ _________.

About Bellevue Life Sciences Acquisition

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

BLAC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BLAC Stock News Headlines

May 13, 2024 | prnewswire.com

Bellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder Meeting

April 21, 2023 | wsj.com

Bellevue Life Sciences Acquisition Corp.

April 18, 2023 | seekingalpha.com

BLACW Bellevue Life Sciences Acquisition Corp. WT EXP 020928

See More Headlines

Receive BLAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 5/31/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Unclassified
Industry: Holding & other investment offices
Sub-Industry: N/A
Current Symbol: NASDAQ:BLAC
CUSIP: N/A
CIK: 1840425
Web: www.bellevuespac.com
Phone: 425-635-7700
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 5,620,000
Free Float: 4,200,000
Market Cap: $60.30 million
Optionable: Not Optionable
Beta: -0.03

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Kuk Hyoun Hwang (Age 48)
CEO & Director
Mr. David Jin Yoo (Age 50)
Chief Financial Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

BLAC Stock Analysis - Frequently Asked Questions

How have BLAC shares performed in 2024?: Bellevue Life Sciences Acquisition's stock was trading at $10.50 at the start of the year. Since then, BLAC stock has increased by 2.2% and is now trading at $10.73.
View the best growth stocks for 2024 here.
Are investors shorting Bellevue Life Sciences Acquisition?: Bellevue Life Sciences Acquisition saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 100 shares, a decline of 92.3% from the April 30th total of 1,300 shares. Based on an average daily volume of 22,600 shares, the days-to-cover ratio is currently 0.0 days.
View Bellevue Life Sciences Acquisition's Short Interest.
Who are Bellevue Life Sciences Acquisition's major shareholders?: Bellevue Life Sciences Acquisition's stock is owned by a variety of institutional and retail investors. Top institutional investors include Berkley W R Corp (5.74%), Wealthspring Capital LLC (0.61%) and K2 Principal Fund L.P. (0.60%).
How do I buy shares of Bellevue Life Sciences Acquisition?: Shares of BLAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BLAC) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial